REPLIGEN CORP acquires C Technologies, Inc.

REPLIGEN CORP acquired C Technologies, Inc. for ~$240 million ($192M cash + $48M in Repligen stock), a transaction completed in May 2019, structured as combination (cash plus stock).

C Technologies, Inc. operates in Process Analytics, is based in Bridgewater, New Jersey, USA, had revenue of about ~$16-$17 million projected annual revenue contribution. Acquisition of privately held C Technologies, Inc., maker of the SoloVPE and FlowVPE Slope Spectroscopy systems for real-time protein concentration measurement, establishing Repligen's Process Analytics franchise. Projected to contribute ~$16-$17 million in revenue.

Hunt said 'the addition of C Technologies is a major step forward in building out a Process Analytics franchise for Repligen,' with plans to develop the core Slope Spectroscopy technology for real-time bioprocess applications.

Differentiated real-time PAT technology with strong growth. Founded a new Process Analytics franchise alongside filtration/chromatography/proteins. Repligen Process Analytics franchise

The addition of C Technologies is a major step forward in building out a Process Analytics franchise for Repligen. We look forward to further developing the core Slope Spectroscopy technology for real-time bioprocess applications.Tony J. Hunt, President and CEO, Repligen

We are very proud of the progress and impact we have made in biopharma over the past decade. Our culture of technology innovation and customer centricity is what differentiates us.Craig Harrison, President and CEO, C Technologies

Advisory firms were not disclosed for this transaction.

You're subscribed.

Thanks for signing up.